Expert: FTC Clinical Data Requirements A Likely Challenge For Medtech Companies

The randomized clinical trial (RCT) requirements in the Federal Trade Commission’s updatedHealth Products Compliance Guidanceare going to be challenging for medical device companies, Sidley Austin LLP partner Jeff Senger told Medtech Insight.

All health-related claims need to be backed with high-quality RCTs under the new FTC guidance,